|
|
|
|
| 6th European Congress on Tropical Medicine and International Health | | September 6 - 10, 2009 Verona, Italy | | 1st Mediterranean Conference on Migration and Travel Health |
|
|
|
|
|
|
|
|
|
|
|
|
|
Thursday, 10 September 2009
|
|
|
Meet the Professor
Room 1 | 08.30 – 09.15
Christian Lengeler (Switzerland)
Moving from research to control programme implementation
|  | Clinical Session
Room 2 | 08.30 – 09.15
Manuel Corachan (Spain)
Spot Diagnosis
|
| Meet the Professor
Room 3 | 08.30 – 09.15
Pascal Lutumba (Congo)
Research capacity strenghtening for NTD. Sleeping sickness research in DR Congo
|
| Meet the Professor
Room 4 | 08.30 – 09.15
Renaud Piarroux (France)
Dynamics and control strategies of cholera epidemics in the African region of the Great Lakes
|
|
|
|
|
T2P8 P.vivax & others including P.knowlesi. Do they really matter ?
Auditorium | 09.30 – 11.00 | Parallel Session
| | | Chair: Carlo Severini (Italy) | | | Keynote Speakers: |
| Indra Vythilingam (Malaysia)
Update on the fifth human plasmodium |
| Azucena Bardaji (Spain)
Plasmodium vivax infection in pregnancy |
| T2P8-01
Evaluation of Plasmodium vivax genotyping markers for molecular epidemiology
I. Felger, C. Koepfli, I. Mueller, S. Schoepflin, P. Zimmermann and H.-P. Beck |
| T2P8-02
Human Plasmodium knowlesi infections in Central Vietnam
P. Van Den Eede, H. Nguyen Van, C. Van Overmeir, I. Vythilingam, T. Ngo
Duc, X. Nguyen Xuan, H. Le Xuan, H. Nguyen Manh, J. Anne, U.
D’Alessandro and A. Erhart |
| T2P8-03
Naturally Acquired Antibodies to Plasmodium vivax Duffy Binding Protein in Rural Amazon
F. Souza-Silva, I. Ceravolo, M. da Silva-Nunes, C. F. A. Brito, M. U. Ferreira and L. H. Carvalho |
| T2P8-04
Adherence to 7 day primaquine treatment for Plasmodium vivax in the Peruvian Amazon
K. Peeters Grietens, A. Erhart, U. D’Alessandro, A. Llanos Cuentas and D. Gamboa |
|
|
|
|
T4 Unfinished business on the road to elimination : experiences, needs, and priorities in accessing patients and adequate health tools to treat Chagas disease and sleping sickness (DNDI)
Room 1 | 9.15 – 11.00 | Workshop | | | Speakers: | | Manica Balasegaram (Switzerland)
Building Innovative Partnerships to Ensure Needs-Driven R&D Delivers Improved Tools for Neglected Diseases
|
| Francois Chappuis (Switzerland)
Sleeping sickness is not asleep everywhere: the challenge of controlling human African trypanosomiasis in remote and unstable areas of Central African Republic and the Democratic Republic of Congo |
| Gemma Ortiz (Médecins Sans Frontières-Spain)
Breaking the Silence: Campaigning to wake up the world to the needs of the most neglected. How can you be involved?
| | Film highlights
Selections from film: "Chagas: A Hidden Affliction" by Ricardo Preve and CNN coverage of MSF treatment centers in the field
Audience discussion with panel on how to better marry disease research, control, and advocacy |
|
|
|
|
T3P5 Challenges in HIV and TB diagnosis
Room 3 | 9.30 – 11.00 | Parallel Session | | Chair and Keynote Speaker: Daniela Cirillo (Italy)
TB diagnosis: The role of microscopy, culture and rapid tests
| | T3P5-01
Clinical, radiological and bacteriological profile of Tuberculosis in a West African country: preliminary data from the National Reference Centre for
Tuberculosis in Bissau, Guinea Bissau
R. Colombatti, F. Cattelan, F. Vieira, E. Martins, C. Silva Vieira, E. Benetti and F. Riccardi
|
| T3P5-02
Missed opportunities for early tuberculosis case detection among
patients with cough of less than two weeks: a study among outpatients
in urban Dar-es-Salaam, Tanzania
E. Ngadaya, S. G. Mfinanga, E. Wandwalo and O. Morkve
| | T3P5-03
Evaluation of chitin-sedimentation and sonication for concentrating Mycobacterium tuberculosis in diagnostic sputum samples
R. Chew, L. Caviedes, P. Fuentes, J. Coronel, R. Gilman, M. Zimic, B. Hererra, T. Valencia and C. Evans
|
| T3P5-04
Rapid drug sensitivity testing of mycobacteria by culture on a highly porous ceramic support
B. Mulder, A. Fares, K. Nolsen and C. Ingham |
| T3P5-05
Molecular Analysis of Isoniazid Resistance in Different Genotypes of Mycobacterium tuberculosis Isolates from Iran
A. Khosravi, F. Doustdar, P. Farnia and A. R. Bahrem
|
| T3P5-06
Caring for African caregivers: morbidity profile among the hospital staff in Tete, Mozambique
E. Carrillo Casas, A. De Weggheleire, T. Decroo, B. Jesus Maria, L. Cumba, R. Maendaenda, C. Das Dores and E. Bottieau |
| T3P5-07
Implementing opt-out testing strategy in a provincial hospital in Mozambique
E. Carrillo Casas, O. Artur Dos Santos, A. De Weggheleire, L. Cumba, R. Maendaenda, C. Das Dores and E. Bottieau |
|
|
|
|
T4 Cost effectiveness of helminth control programme, the example of Cambodia
Room 4 | 9.30 – 11.00 | Round Table | | | Moderator:
Lorenzo Savioli (World Health Organization) |
| | | Speakers: | | | Antonio Montresor (World Health Organization)
Safety and benefits of drug co-administration
|
| | Marco Albonico (Italy)
Potential drug resistance in helminth control programmes
| | | Juerg Utzinger (Switzerland)
Diagnostic dilemmas in Helminth control |
| |
|
|
|
From research to action
Closing Session
Auditorium | 11.30 – 13.00 |
| | Chair: Zeno Bisoffi (Italy), Manuel Corachan (Spain)
Summary of the main outcomes of the Congress | | | Speaker:
Bruno Gryseels (Belgium)
Roles and responsibilities in implementing research findings | | |
|
|
|
|
|
|
|
|
|
|
|
|
|
